Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs

Journal of Sichuan University (Medical Science)

Volumn 38, Issue 1, 2007, Pages 57-59

  Ye, Xue Shi ^a   Liu, Ting ^a   Cui, Xu ^a   Meng, Wen Tong ^a   Xi, Ya Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

As2O3; Decitabine; Myelodysplastic syndromes; P15INK4B gene methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ARSENIC TRIOXIDE; CYCLIN DEPENDENT KINASE INHIBITOR 2B; AZACITIDINE; DRUG DERIVATIVE; ORGANOARSENIC DERIVATIVE; OXIDE;

ACUTE LEUKEMIA; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; METHYLATION; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; DNA METHYLATION; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; LEUKEMIA; PATHOLOGY;

ARSENICALS; AZACITIDINE; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DISEASE PROGRESSION; DNA METHYLATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA; MYELODYSPLASTIC SYNDROMES; OXIDES;

EID: 33846602850     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. B gene in myelodysplastic syndromes. Blood, 1997; 90(4):1403-1409.
2. B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients. Leukemia, 2001;15(10):1589-1595.
3. Chinese source
4. Silverman LR, Holland JF, Weinberg RS, et al. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes. Leukemia, 1993;7(Suppl 1):21-29.
5. B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood, 2002;100(8):2957-2964.
6. Chinese source